Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of St Andrews Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Reading Featured PhD Programmes
"cancer" AND "bioinformat…×
10 miles

cancer bioinformatics PhD Projects, Programs & Scholarships

We have 66 cancer bioinformatics PhD Projects, Programs & Scholarships

  • "cancer" AND "bioinformatics" ×
  • clear all
Order by 
Showing 1 to 10 of 66
  Clinical cancer bioinformatics: developing new bioinformatics methods for improved analysis of cancer gene hybridisation capture panels
  Prof A Papenfuss
Applications accepted all year round
Bioinformatics is the application of mathematics, statistics and computational methods to the analysis of molecular biology data.
  Analytic methods for detecting and making sense of somatic genomic rearrangements
  Prof A Papenfuss
Applications accepted all year round
Bioinformatics is the application of mathematics, statistics and computational methods to the analysis of molecular biology data.
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round
P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round
Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Immunostaging for melanoma to accurately predict the risk of relapse after surgery
  Prof A Papenfuss
Applications accepted all year round
This project will utilise a large biobank of clinically annotated samples from patients with melanoma at high risk of relapse after surgery to develop a signature that predicts risk of relapse.
  MRC Precision Medicine DTP: Stromal transcriptomic signatures in prostate cancer metastasis and hormone therapy resistance
  Research Group: MRC Centre for Reproductive Health
  Dr B-Z Qian, Prof H Y Leung, Dr A Sims, Prof P Wiklund
Application Deadline: 7 January 2019
Background. A tremendous amount of cancer ‘-omics’ data have been generated with the intention to stratify patients for personalized diagnosis and treatment.
  MRC Precision Medicine DTP: Quantitative proteomic analysis of dysregulated adhesion protein localisation in patient-derived cancer cells
  Research Group: Edinburgh Cancer Research Centre
  Dr A Byron, Prof M Frame, Prof R Zubarev, Dr A Sims
Application Deadline: 7 January 2019
Summary. This project seeks to use proteomic data and computational approaches to identify signatures of cell adhesion proteins that are mislocalised in cells from brain cancer patients.
  MRC Precision Medicine DTP: Molecular pathology data science studies of breast cancer
  Dr J Figueroa, Dr A Sims, Assoc Prof N Tobin
Application Deadline: 7 January 2019
BACKGROUND. Datasets linked to molecular phenotypes are desperately needed to provide academia and industry the real-world evidence needed for discovery, validation and implementation of new biomarkers for improved cancer outcomes.
  MRC DiMeN Doctoral Training Partnership: Proteomics approaches to discover new roles for non-canonical signalling in cancer
  Prof C Eyers, Prof A Jones
Application Deadline: 21 January 2019
Supervisor team. Prof. Claire E. Eyers (Department of Biochemistry, Institute of Integrative Biology, University of Liverpool). https://www.liverpool.ac.uk/integrative-biology/staff/claire-eyers/.
  DNA Damage and Repair: Studying DNA damage and repair to understand the causes of cancer and improve its treatment
  Prof P McHugh, Prof J Rehwinkel, Prof A Harris
Application Deadline: 11 January 2019
Our DNA is constantly under threat from damaging agents. If unrepaired this DNA damage can lead to errors during genome duplication, including the mutations that can lead to cancer and other human diseases.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.